GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Price-to-Owner-Earnings

LungLife AI (LSE:LLAI) Price-to-Owner-Earnings : (As of Jun. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Price-to-Owner-Earnings?

As of today (2024-06-20), LungLife AI's share price is £0.17. LungLife AI does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for LungLife AI's Price-to-Owner-Earnings or its related term are showing as below:


LSE:LLAI's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.37
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-20), LungLife AI's share price is £0.17. LungLife AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.17. Therefore, LungLife AI's PE Ratio for today is At Loss.

As of today (2024-06-20), LungLife AI's share price is £0.17. LungLife AI's EPS without NRI for the trailing twelve months (TTM) ended in was £-0.17. Therefore, LungLife AI's PE Ratio without NRI for today is At Loss.


LungLife AI Price-to-Owner-Earnings Historical Data

The historical data trend for LungLife AI's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Price-to-Owner-Earnings Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of LungLife AI's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, LungLife AI's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LungLife AI's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LungLife AI's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where LungLife AI's Price-to-Owner-Earnings falls into.



LungLife AI Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

LungLife AI's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.17/-0.17
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LungLife AI  (LSE:LLAI) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


LungLife AI Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of LungLife AI's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


LungLife AI (LSE:LLAI) Business Description

Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines